Evidence map›Paper›PMID 28507025›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Cutting Edge: Defective Aerobic Glycolysis Defines the Distinct Effector Function in Antigen-Activated CD8

Cody A Cunningham, Tessa Bergsbaken, Pamela J Fink

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. The impact of the gut microbiota on T cell ontogeny in the thymus.Cellular and molecular life sciences : CMLS · 2022
    Review
  4. Review
  5. Review
  6. Dissecting the defects in the neonatal CD8Journal of leukocyte biology · 2019
    Review
  7. Article
  8. Article
  9. The full spectrum of human naive T cells.Nature reviews. Immunology · 2018
    Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cody A CunninghamDepartment of Immunology, University of Washington, Seattle, WA 98109.
Tessa BergsbakenDepartment of Immunology, University of Washington, Seattle, WA 98109.
Pamela J FinkDepartment of Immunology, University of Washington, Seattle, WA 98109 pfink@uw.edu.ORCID 0000-0002-7559-5948
University of Washington · US

Funding

Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
CHARACTERIZATION OF RECENT THYMIC EMIGRANTSR01AI064318 · NIAID · UNIVERSITY OF WASHINGTON · PI URDAHL, KEVIN B · 2005 to 2019
$5.8M
NIAID NIH HHS R01 AI064318NIDDK NIH HHS T32 DK007247
6 · The paper itself

Abstract

Recent thymic emigrants (RTEs) are the youngest peripheral T cells that have completed thymic selection and egress to the lymphoid periphery. RTEs are functionally distinct from their more mature but still naive T cell counterparts, because they exhibit dampened proliferation and reduced cytokine production upon activation. In this article, we show that, compared with more mature but still naive T cells, RTEs are impaired in their ability to perform aerobic glycolysis following activation. Impaired metabolism underlies the reduced IFN-γ production observed in activated RTEs. This failure to undergo Ag-induced aerobic glycolysis is caused by reduced mTORC1 activity and diminished Myc induction in RTEs. Critically, exogenous IL-2 restores Myc expression in RTEs, driving aerobic glycolysis and IFN-γ production to the level of mature T cells. These results reveal a previously unknown metabolic component to postthymic T cell maturation.

Indexed as

Cell MovementGlycolysisLymphocyte ActivationAnimalsCD8-Positive T-LymphocytesCell DifferentiationGenes, mycInterferon-gammaInterleukin-2Mechanistic Target of Rapamycin Complex 1MiceMultiprotein ComplexesThymus GlandTOR Serine-Threonine KinasesInterferon-gammaInterleukin-2Mechanistic Target of Rapamycin Complex 1Multiprotein ComplexesTOR Serine-Threonine Kinases

Identifiers

PMID28507025
PMCPMC5499662
OpenAlexW2614911356

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.